MECOM is a master repressor of myeloid differentiation through dose control of <i>CEBPA</i> in acute myeloid leukemia
Dorien Pastoors(Oncode Institute), Ruud Delwel(Oncode Institute)
Cited by 2
Related Papers
Oncogene <i>EVI1</i> drives acute myeloid leukemia via a targetable interaction with CTBP2
|Science Advances|2024|16